Brittany Ahmed, MD
Rheumatology · Tacoma, WANPI 1609211911
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.5%), consulting fees and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Sanofi at 41.9% of the total. Reporting peaked in 2021 at $1,704 and has fallen 99.2% since, to $14 in 2025.
Across 73 payments — averaging $55.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- AbbVie$1K
- Amgen$310
- GSK$214
- Lilly USA, LLC$191
- Novartis$135
- plus $302 from 5 others
What the payments were for
- Consulting fees$1,65541%
- Food & beverage$2,31658%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 3 | $1,688 |
| AbbVie | 26 | $1,186 |
| Amgen(2 entities) | 13 | $310 |
| GSK | 6 | $214 |
| Lilly USA, LLC | 7 | $191 |
| Novartis | 2 | $135 |
| Pfizer | 7 | $133 |
| UCB, Inc. | 5 | $84 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Boston Scientific | 2 | $30 |
| Bristol Myers Squibb | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,027 in reported general payments places this provider in the 75th percentile of 157 rheumatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Tacoma
- Robert EttlingerTacoma$232K
- Patricia PapadopoulosTacoma$2K
- Daniel Ene-StroescuTacoma$1K
- Yun Sun ChoeTacoma$1K
- Ofelya GevorgyanTacoma$909
- Stanford PengSeattle$3.5M
- Jeff PetersonBothell$2.3M
- Philip MeaseSeattle$2.1M
- Richard JimenezBothell$155K
- Howard KenneySpokane$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.